{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:28:16Z","timestamp":1774502896771,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T00:00:00Z","timestamp":1466467200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s12325-016-0360-3","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T18:58:08Z","timestamp":1466621888000},"page":"1374-1384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Role of Side Effects, Physician Involvement, and Patient Perception in Non-Adherence with Oral Bisphosphonates"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5317-2848","authenticated-orcid":false,"given":"Inbal","family":"Goldshtein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Rouach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naama","family":"Shamir-Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Chodick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,21]]},"reference":[{"issue":"8","key":"360_CR1","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"Kanis JA, Melton LR, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137\u201341.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"360_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","volume":"148","author":"C MacLean","year":"2008","unstructured":"MacLean C, Newberry S, Maglione M, et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med. 2008;148(3):197\u2013213.","journal-title":"Ann Intern Med"},{"issue":"1","key":"360_CR3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00198-011-1535-z","volume":"23","author":"P Hadji","year":"2012","unstructured":"Hadji P, Claus V, Ziller V, Intorcia M, Kostev K, Steinle T. GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates. Osteoporos Int. 2012;23(1):223\u201331.","journal-title":"Osteoporos Int"},{"issue":"11","key":"360_CR4","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00198-009-1134-4","volume":"21","author":"I Imaz","year":"2010","unstructured":"Imaz I, Zegarra P, Gonzalez-Enriquez J, Rubio B, Alcazar R, Amate JM. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int. 2010;21(11):1943\u201351.","journal-title":"Osteoporos Int"},{"issue":"6","key":"360_CR5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bone.2005.10.022","volume":"38","author":"KF Huybrechts","year":"2006","unstructured":"Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone. 2006;38(6):922\u20138.","journal-title":"Bone"},{"issue":"14","key":"360_CR6","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1517\/14656560903140533","volume":"10","author":"V Rabenda","year":"2009","unstructured":"Rabenda V, Hiligsmann M, Reginster JY. Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence. Expert Opin Pharmacother. 2009;10(14):2303\u201315.","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"360_CR7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.18553\/jmcp.2009.15.9.728","volume":"15","author":"J Yeaw","year":"2009","unstructured":"Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Managed Care Pharm JMCP. 2009;15(9):728\u201340.","journal-title":"J Managed Care Pharm JMCP."},{"issue":"8","key":"360_CR8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","volume":"81","author":"ES Siris","year":"2006","unstructured":"Siris ES, Harris ST, Rosen CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc. 2006;81(8):1013\u201322.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"360_CR9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00198-007-0506-x","volume":"19","author":"V Rabenda","year":"2008","unstructured":"Rabenda V, Mertens R, Fabri V, et al. Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int. 2008;19(6):811\u20138.","journal-title":"Osteoporos Int"},{"issue":"2 Suppl","key":"360_CR10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.12.002","volume":"122","author":"ES Siris","year":"2009","unstructured":"Siris ES, Selby PL, Saag KG, Borgstrom F, Herings RM, Silverman SL. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med. 2009;122(2 Suppl):S3\u201313.","journal-title":"Am J Med."},{"issue":"4","key":"360_CR11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jval.2010.11.010","volume":"14","author":"S Ross","year":"2011","unstructured":"Ross S, Samuels E, Gairy K, Iqbal S, Badamgarav E, Siris E. A meta-analysis of osteoporotic fracture risk with medication nonadherence. Value Health. 2011;14(4):571\u201381.","journal-title":"Value Health"},{"issue":"2","key":"360_CR12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.healthpol.2010.01.014","volume":"96","author":"M Hiligsmann","year":"2010","unstructured":"Hiligsmann M, Rabenda V, Bruyere O, Reginster JY. The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients. Health Policy. 2010;96(2):170\u20137.","journal-title":"Health Policy"},{"issue":"3","key":"360_CR13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40266-014-0153-9","volume":"31","author":"O Mukhtar","year":"2014","unstructured":"Mukhtar O, Weinman J, Jackson SH. Intentional non-adherence to medications by older adults. Drugs Aging. 2014;31(3):149\u201357.","journal-title":"Drugs Aging"},{"issue":"1","key":"360_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","volume":"14","author":"R Horne","year":"1999","unstructured":"Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1\u201324.","journal-title":"Psychol Health."},{"issue":"7","key":"360_CR15","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s11136-014-0662-3","volume":"23","author":"K Reynolds","year":"2014","unstructured":"Reynolds K, Viswanathan HN, Muntner P, et al. Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates. Qual Life Res. 2014;23(7):2109\u201320.","journal-title":"Qual Life Res"},{"key":"360_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1477-7525-4-42","volume":"4","author":"EM Flood","year":"2006","unstructured":"Flood EM, Beusterien KM, Green H, et al. Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women. Health Qual Life Outcomes. 2006;4:42.","journal-title":"Health Qual Life Outcomes."},{"issue":"2","key":"360_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF02672508","volume":"8","author":"JM Chandler","year":"1998","unstructured":"Chandler JM, Martin AR, Girman C, et al. Reliability of an Osteoporosis-Targeted Quality of Life Survey Instrument for use in the community: OPTQoL. Osteoporos Int. 1998;8(2):127\u201335.","journal-title":"Osteoporos Int"},{"issue":"3","key":"360_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00198-002-1370-3","volume":"14","author":"B Hamilton","year":"2003","unstructured":"Hamilton B, McCoy K, Taggart H. Tolerability and compliance with risedronate in clinical practice. Osteoporos Int. 2003;14(3):259\u201362.","journal-title":"Osteoporos Int"},{"issue":"2","key":"360_CR19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0149-2918(04)90023-9","volume":"26","author":"C Turbi","year":"2004","unstructured":"Turbi C, Herrero-Beaumont G, Acebes JC, et al. Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study. Clin Ther. 2004;26(2):245\u201356.","journal-title":"Clin Ther"},{"issue":"12","key":"360_CR20","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1185\/030079907X242890","volume":"23","author":"CA McHorney","year":"2007","unstructured":"McHorney CA, Schousboe JT, Cline RR, Weiss TW. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates. Curr Med Res Opin. 2007;23(12):3137\u201352.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"360_CR21","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1185\/03007991003633603","volume":"26","author":"C Woo","year":"2010","unstructured":"Woo C, Gao G, Wade S, Hochberg MC. Gastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US study. Curr Med Res Opin. 2010;26(4):1003\u20139.","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"360_CR22","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane E, Burr D, Ebeling PR, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010;25(11):2267\u201394.","journal-title":"J Bone Miner Res."},{"issue":"1","key":"360_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014;29(1):1\u201323.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"360_CR24","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007;22(10):1479\u201391.","journal-title":"J Bone Miner Res."},{"issue":"2 Suppl","key":"360_CR25","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.amjmed.2008.12.005","volume":"122","author":"SL Silverman","year":"2009","unstructured":"Silverman SL, Landesberg R. Osteonecrosis of the jaw and the role of bisphosphonates: a critical review. Am J Med. 2009;122(2 Suppl):S33\u201345.","journal-title":"Am J Med."},{"issue":"7","key":"360_CR26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrendo.2015.71","volume":"11","author":"IR Reid","year":"2015","unstructured":"Reid IR. Short-term and long-term effects of osteoporosis therapies. Nat Rev Endocrinol. 2015;11(7):418\u201328.","journal-title":"Nat Rev Endocrinol."},{"issue":"12","key":"360_CR27","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1007\/s00198-013-2364-z","volume":"24","author":"M Hiligsmann","year":"2013","unstructured":"Hiligsmann M, Salas M, Hughes DA, et al. Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence and Persistence Special Interest Group. Osteoporos Int. 2013;24(12):2907\u201318.","journal-title":"Osteoporos Int"},{"issue":"2","key":"360_CR28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pec.2010.03.010","volume":"81","author":"D Nielsen","year":"2010","unstructured":"Nielsen D, Ryg J, Nielsen W, Knold B, Nissen N, Brixen K. Patient education in groups increases knowledge of osteoporosis and adherence to treatment: a two-year randomized controlled trial. Patient Educ Couns. 2010;81(2):155\u201360.","journal-title":"Patient Educ Couns"},{"issue":"6","key":"360_CR29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1062860607307990","volume":"22","author":"PF Cook","year":"2007","unstructured":"Cook PF, Emiliozzi S, McCabe MM. Telephone counseling to improve osteoporosis treatment adherence: an effectiveness study in community practice settings. Am J Med Qual. 2007;22(6):445\u201356.","journal-title":"Am J Med Qual."},{"issue":"11","key":"360_CR30","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1359\/jbmr.070717","volume":"22","author":"DH Solomon","year":"2007","unstructured":"Solomon DH, Katz JN, Finkelstein JS, et al. Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res. 2007;22(11):1808\u201315.","journal-title":"J Bone Miner Res."},{"issue":"7","key":"360_CR31","first-page":"417","volume":"15","author":"AD Shu","year":"2009","unstructured":"Shu AD, Stedman MR, Polinski JM, et al. Adherence to osteoporosis medications after patient and physician brief education: post hoc analysis of a randomized controlled trial. Am J Manag Care. 2009;15(7):417\u201324.","journal-title":"Am J Manag Care."},{"issue":"3","key":"360_CR32","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1210\/jc.2003-030501","volume":"89","author":"JA Clowes","year":"2004","unstructured":"Clowes JA, Peel NF, Eastell R. The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab. 2004;89(3):1117\u201323.","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"360_CR33","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2006-1526","volume":"92","author":"PD Delmas","year":"2007","unstructured":"Delmas PD, Vrijens B, Eastell R, et al. Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab. 2007;92(4):1296\u2013304.","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"360_CR34","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s00198-004-1818-8","volume":"16","author":"CS Pickney","year":"2005","unstructured":"Pickney CS, Arnason JA. Correlation between patient recall of bone densitometry results and subsequent treatment adherence. Osteoporos Int. 2005;16(9):1156\u201360.","journal-title":"Osteoporos Int"},{"issue":"3","key":"360_CR35","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00198-011-1721-z","volume":"23","author":"SL Silverman","year":"2012","unstructured":"Silverman SL, Nasser K, Nattrass S, Drinkwater B. Impact of bone turnover markers and\/or educational information on persistence to oral bisphosphonate therapy: a community setting-based trial. Osteoporos Int. 2012;23(3):1069\u201374.","journal-title":"Osteoporos Int"},{"issue":"6","key":"360_CR36","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.berh.2009.09.007","volume":"23","author":"J Compston","year":"2009","unstructured":"Compston J. Monitoring osteoporosis treatment. Best Pract Res Clin Rheumatol. 2009;23(6):781\u20138.","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"9548","key":"360_CR37","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/S0140-6736(06)69691-8","volume":"368","author":"A Cooper","year":"2006","unstructured":"Cooper A. Compliance with treatment for osteoporosis. Lancet. 2006;368(9548):1648.","journal-title":"Lancet"},{"issue":"6","key":"360_CR38","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00198-010-1378-z","volume":"22","author":"DL Kendler","year":"2011","unstructured":"Kendler DL, McClung MR, Freemantle N, et al. Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate. Osteoporos Int. 2011;22(6):1725\u201335.","journal-title":"Osteoporos Int"},{"issue":"1","key":"360_CR39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00198-011-1780-1","volume":"23","author":"N Freemantle","year":"2012","unstructured":"Freemantle N, Satram-Hoang S, Tang ET, et al. Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women. Osteoporos Int. 2012;23(1):317\u201326.","journal-title":"Osteoporos Int"},{"issue":"1","key":"360_CR40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00198-009-0930-1","volume":"21","author":"FE Cotte","year":"2010","unstructured":"Cotte FE, Fardellone P, Mercier F, Gaudin AF, Roux C. Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis. Osteoporos Int. 2010;21(1):145\u201355.","journal-title":"Osteoporos Int"},{"issue":"3","key":"360_CR41","first-page":"236","volume":"202","author":"DA Hill","year":"2010","unstructured":"Hill DA, Cacciatore M, Lamvu GM. Electronic prescribing influence on calcium supplementation: a randomized controlled trial. Am J Obstetr Gynecol. 2010;202(3):236.","journal-title":"Am J Obstetr Gynecol."},{"key":"360_CR42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12877-015-0099-8","volume":"15","author":"SH Alamri","year":"2015","unstructured":"Alamri SH, Kennedy CC, Marr S, Lohfeld L, Skidmore CJ, Papaioannou A. Strategies to overcome barriers to implementing osteoporosis and fracture prevention guidelines in long-term care: a qualitative analysis of action plans suggested by front line staff in Ontario, Canada. BMC Geriatr. 2015;15:94.","journal-title":"BMC Geriatr."},{"issue":"5\u20136","key":"360_CR43","first-page":"321","volume":"70","author":"JY Reginster","year":"2015","unstructured":"Reginster JY, Neuprez A, Lecart MP, et al. Osteoporosis and personalized medicine. Rev Med Liege. 2015;70(5\u20136):321\u20134.","journal-title":"Rev Med Liege"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-016-0360-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-016-0360-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-016-0360-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:52:19Z","timestamp":1498308739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-016-0360-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,21]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1007\/s12325-016-0360-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,21]]}}}